LIVTENCITY 200 mg film coated tablets
*Company:
Takeda Products Ireland LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 27 March 2024
File name
livtencity-mar24-smpc-ie_clean.pdf
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 5.3 - Preclinical safety data
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
SmPC update and minor corrections:
4.5, 4.8, 5.1, 5.2, 5.3, 10
Updated on 27 February 2024
File name
Livtencity Ireland SPC Feb24 - launch.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
First published SmPC
Updated on 27 February 2024
File name
Livtencity Ireland PIL Feb24 - launch.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
The first published patient information leaflet